Roundtable Discussion: Aligning Assay Strategy with Regulatory Expectations to Streamline Cell Therapy Testing
- Exploring how to match functional and safety assays with regulatory requirements to ensure robust testing strategies
- Evaluating the use of quality testing for virus replication in cell therapy products despite minimal risk to balance regulatory compliance and assay costs
- Sharing insights on balancing regulatory compliance with scientific rationale to reduce unnecessary testing while maintaining patient safety